PEPTIDES 2019
Chairs: Malcolm Buckle & Michelle Hill
The oncogenic lncRNA RP11-499F3.2 promotes tumorigenesis and cetuximab resistance via activation of Wnt2B signaling (#1)
8:30 AM
Mediator Lipidomics: Towards Comprehensive Metabolic Profiling of Eicosanoids and Related Fatty Acids (#2)
9:00 AM
Reforming the Regulatory Environment for Innovative Health Technologies: Identifying Congestion and Filling Gaps (#3)
9:30 AM
Patentomics: personalised protection (#4)
10:00 AM